Adam C. Vandervoort - 01 Sep 2026 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)

Reporting relationship: CHIEF LEGAL OFFICER, SECRETARY
Issuer ticker: TDOC
Reported as of: 01 Sep 2026
Net transaction value: -$47,717
SEC form: 4
Accepted by SEC: 03 Sep 2026, 16:05:58 UTC
Prior SEC filing: 03 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Adam C. Vandervoort

Key filing fact

Adam C. Vandervoort filed Form 4 for Teladoc Health, Inc. (TDOC) on 03 Sep 2026.

Key facts

This page summarizes Adam C. Vandervoort's Form 4 filing for Teladoc Health, Inc. (TDOC).
7 reported transactions and 3 derivative rows are listed below.
Accepted by SEC: 03 Sep 2026, 16:05.

Change

Previous filing in this sequence was filed on 03 Jun 2026.
Current net transaction value: -$47,717.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001375088 Primary reporting owner

Vandervoort Adam C

Relationship: CHIEF LEGAL OFFICER, SECRETARY
Address: C/O TELADOC HEALTH, INC.,, 155 E 44TH ST, SUITE 1700, NEW YORK
Signature: /s/ Adam C. Vandervoort
Signature date: 03 Sep 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TDOC transaction

Common Stock

Options Exercise

Transaction value
Shares: +5,350
Change %: +4.9%
Price
Shares after: 115,611
Date: 01 Sep 2026
Ownership: Direct
Footnotes: F1

TDOC transaction

Common Stock

Options Exercise

Transaction value
Shares: +9,152
Change %: +7.9%
Price
Shares after: 124,763
Date: 01 Sep 2026
Ownership: Direct
Footnotes: F1

TDOC transaction

Common Stock

Options Exercise

Transaction value
Shares: +426
Change %: +0.34%
Price
Shares after: 125,189
Date: 01 Sep 2026
Ownership: Direct
Footnotes: F2

TDOC transaction

Common Stock

Sale

Transaction value: $47,717
Shares: -7,573
Change %: -6%
Price: $6.30
Shares after: 117,616
Date: 02 Sep 2026
Ownership: Direct
Footnotes: F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TDOC transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
Shares: -5,350
Change %: -33%
Price: $0.000000^*
Shares after: 10,700
Date: 01 Sep 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 5,350
Exercise price
Footnotes: F1, F4

TDOC transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
Shares: -9,152
Change %: -14%
Price: $0.000000^*
Shares after: 54,918
Date: 01 Sep 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 9,152
Exercise price
Footnotes: F1, F5

TDOC transaction Derivative

Performance Stock Units

Options Exercise

Transaction value
Shares: -426
Change %: -14%
Price: $0.000000^*
Shares after: 2,553
Date: 01 Sep 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 426
Exercise price
Footnotes: F2, F6

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 6 footnotes

Footnote F1

Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.

Footnote F2

Performance stock units convert to shares of TDOC common stock on a one-for-one basis.

Footnote F3

Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.

Footnote F4

On March 19, 2024, the reporting person was granted 64,200 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025.

Footnote F5

On March 1, 2025, the reporting person was granted 109,832 restricted stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter.

Footnote F6

On March 1, 2026, the reporting person earned 5,107 performance stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter.